2-4 July 2017, Paris, France
Top Ophthalmologists from around the globe will be present to share their knowledge and discuss major advances in our field. The theme this year is "Imaging and Managing Macular Diseases".
The scientific program will include clinical case sessions, poster sessions, free paper sessions, and 14 faculty sessions dedicated to exudative AMD, vein occlusion, diabetic maculopathy, myopic maculopathy, uveitis, and much more. Abstract submission deadline is February 27, 2017. Early bird registration deadline is April 15, 2017.
3 July 2017, Brussels, Belgium
Against the backdrop of the Commission's White Paper on the future of Europe, the conference "Research & Innovation – shaping our future", hosted by Research, Science and Innovation Commissioner Carlos Moedas, will bring together policymakers from EU institutions, nearly 700 stakeholders and interested actors to discuss the role of research and innovation for Europe's future.
Pascal Lamy, the chair of the High Level Group on maximising the impact of European research and innovation programmes, will present the Group's vision and recommendations for the future, based on the results of the interim evaluation of Horizon 2020.
The conference will build further momentum for research and innovation as an investment for our future by:
Stakeholders have already confirmed the attractiveness of Horizon 2020 as a well-performing programme and a key investment in safeguarding our future. Europe is home to leading global companies, top universities and frontier research and technology centres.
How to capitalise on these strengths in order to face up to the challenges of a changing world and rapidly evolving innovation dynamics? How to best seize the opportunities and research and innovation capital we have to create solutions for the future? What is the role of the European research and innovation in a global context? How can research and innovation shape future of our citizens? These are the questions we would like to answer today in order to face our future tomorrow.
Visionary speakers will include Nobel Prize winners, captains of industry, researchers and innovators at the frontier of progress, politicians and movers and shakers in society but also youngsters who have expectations for the(ir) future. They will discuss with the audience how research and innovation could transform our economy and improve our society.
Updates to follow
3-5 July 2017, Innsbruck, Austria
The aim of this interactive workshop is to provide practical insights into basic and translational neuroscience research for interested non-specialists.
The topics addressed range from essential neuroanatomy and neurophysiology, over IPS cells, to networks and behaviour. Plasticity and modulation of networks and signal transmission under physiological (like learning and memory) and pathological situations (like addiction, epilepsy or neurodegeneration) will form an essential part.
5-7 July 2017, Athens, Greece
The Hellenic Forum is under the auspices of the Hellenic Ministry of Foreign Affairs and aims to act as a meeting point for Science, Technology and Innovation building bridges with scientists abroad, in order to enhance scientific and technological transfer collaboration for innovation.
The Forum will cover a broad range of topics including Nanotechnology, Energy & Environment, Life Sciences, ICT , Particle Physics, Cultural Heritage with emphasis to converging technologies.
5-7 July 2017, Innsbruck, Austria
The aim of this interactive workshop is to deepen and complete the online course on brain medicine for non-specialists with the most recent advances in research of neurodegenerative and neuropsychiatric disorders.
Lectures and tutorials by international experts will report the state of the art of research and treatment of brain diseases. Representatives of the Allen Institute for Brain Science (AI, USA) and the Human Brain Project (HBP, Europe) will present novel avenues for exploiting large biological datasets for future classification of brain diseases, which may lead to new strategies for developing therapeutics.